BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15542397)

  • 1. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum.
    Steinberg S; Chen L; Wei L; Moser A; Moser H; Cutting G; Braverman N
    Mol Genet Metab; 2004 Nov; 83(3):252-63. PubMed ID: 15542397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients.
    Ebberink MS; Kofster J; Wanders RJ; Waterham HR
    Hum Mutat; 2010 Jan; 31(1):E1058-70. PubMed ID: 19877282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder.
    Ebberink MS; Mooijer PA; Gootjes J; Koster J; Wanders RJ; Waterham HR
    Hum Mutat; 2011 Jan; 32(1):59-69. PubMed ID: 21031596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.
    Yik WY; Steinberg SJ; Moser AB; Moser HW; Hacia JG
    Hum Mutat; 2009 Mar; 30(3):E467-80. PubMed ID: 19105186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.
    Krause C; Rosewich H; Thanos M; Gärtner J
    Hum Mutat; 2006 Nov; 27(11):1157. PubMed ID: 17041890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients.
    Warren DS; Wolfe BD; Gould SJ
    Hum Mutat; 2000; 15(6):509-21. PubMed ID: 10862081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients.
    Maxwell MA; Allen T; Solly PB; Svingen T; Paton BC; Crane DI
    Hum Mutat; 2002 Nov; 20(5):342-51. PubMed ID: 12402331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders.
    Crane DI; Maxwell MA; Paton BC
    Hum Mutat; 2005 Sep; 26(3):167-75. PubMed ID: 16086329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders.
    Portsteffen H; Beyer A; Becker E; Epplen C; Pawlak A; Kunau WH; Dodt G
    Nat Genet; 1997 Dec; 17(4):449-52. PubMed ID: 9398848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome biogenesis disorders.
    Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
    Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional classification of Arabidopsis peroxisome biogenesis factors proposed from analyses of knockdown mutants.
    Nito K; Kamigaki A; Kondo M; Hayashi M; Nishimura M
    Plant Cell Physiol; 2007 Jun; 48(6):763-74. PubMed ID: 17478547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor-2) gene in patients with peroxisome biogenesis disorders.
    Zhang Z; Suzuki Y; Shimozawa N; Fukuda S; Imamura A; Tsukamoto T; Osumi T; Fujiki Y; Orii T; Wanders RJ; Barth PG; Moser HW; Paton BC; Besley GT; Kondo N
    Hum Mutat; 1999; 13(6):487-96. PubMed ID: 10408779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
    Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
    Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives.
    Braverman NE; D'Agostino MD; Maclean GE
    Dev Disabil Res Rev; 2013; 17(3):187-96. PubMed ID: 23798008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations.
    Rosewich H; Ohlenbusch A; Gärtner J
    J Med Genet; 2005 Sep; 42(9):e58. PubMed ID: 16141001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes.
    Matsumoto N; Tamura S; Fujiki Y
    Nat Cell Biol; 2003 May; 5(5):454-60. PubMed ID: 12717447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
    Krause C; Rosewich H; Woehler A; Gärtner J
    Hum Mol Genet; 2013 Oct; 22(19):3844-57. PubMed ID: 23716570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational diagnostic strategy for Zellweger syndrome spectrum patients.
    Krause C; Rosewich H; Gärtner J
    Eur J Hum Genet; 2009 Jun; 17(6):741-8. PubMed ID: 19142205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders.
    Reuber BE; Germain-Lee E; Collins CS; Morrell JC; Ameritunga R; Moser HW; Valle D; Gould SJ
    Nat Genet; 1997 Dec; 17(4):445-8. PubMed ID: 9398847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.